Ajude a desenvolver o World Market Atlas, um projeto independente para investidores individuais. O seu apoio permite-nos produzir análises e melhorar as ferramentas.
WORLD MARKET ATLAS · ANÁLISE
Modelos DCF detalhados
Uma empresa, uma análise completa do negócio e uma avaliação detalhada dos fluxos de caixa. Análise de empresas de mercados desenvolvidos com pressupostos, cenários e fontes explícitos.
Arquivo de relatóriosÚLTIMO RELATÓRIO · 7 de novembro de 2026Publicação após revisão do modelo e do PDF
Os resumos das análises e os relatórios PDF mantêm a língua original quando não existe uma tradução disponível.
RELATÓRIO SELECIONADO · 28 de outubro de 2026
SAP SE SAP · Xetra
PDF · 28 páginas · PL
EN SAP: four revenue streams, a full ten-year FCFF, explicit cloud/support migration, SBC, M&A as reinvestment, scenarios, WACC/g and reverse DCF. No rating or recommendation.
Cotação de referência
213,15 EUR
2026-10-27 close, Xetra; secondary delayed history
Cenário DCF base
233,73 EUR
Resultado do modelo, não um preço-alvo
Cenários pessimista / otimista
132–385 EUR
Intervalo de cenários, não um intervalo de confiança
WACC: 8,60%Crescimento na perpetuidade: 2,00%Valor terminal descontado / EV: 60,4%
Limitações e convenções: Screen-grade: delayed secondary quote; sector beta; no paid consensus; FY2026E and the 2027-2036 forecast are author assumptions. Not investment advice.
01 · Qualidade do negócio e dos lucrosSegmentos, concorrência, dados financeiros históricos, balanço, afetação de capital e riscos.
02 · Modelo detalhadoPrevisões de receitas e margens, impostos, investimento de capital, depreciação, fundo de maneio, locações e fluxos de caixa.
03 · Avaliação e verificaçõesCusto de capital, valor terminal, reconciliação do valor do capital próprio, cenários, sensibilidades, fontes e limitações.
Arquivo de relatórios
21 relatórios
Os relatórios mantêm os dados, o modelo e a data de publicação originais. As análises posteriores não atualizam as avaliações históricas.
EN Johnson & Johnson: ten-year Innovative Medicine and MedTech FCFF, full EV/equity bridge including claims, scenarios, two sensitivities and reverse DCF. No rating or recommendation.
GOOGL · Nasdaq Global Select Market · Estados Unidos
EN Alphabet: ten-year six-stream FCFF, separate Cloud and Services, full EV/equity bridge, scenarios, two sensitivities and reverse DCF. No rating or recommendation.
EN Coca-Cola: ten-year five-segment FCFF, bottling refranchising, full EV/equity bridge, scenarios, sensitivity and reverse DCF. No rating or recommendation.
EN Apple: ten-year category-based FCFF, separate Products and Services margins, full EV/equity bridge, scenarios, two sensitivity matrices and reverse DCF. No rating or recommendation.
EN AB Volvo: ten-year Industrial Operations FCFF, separate VFS residual-income model, full EV/equity bridge, three cases, WACC/g and reverse DCF. No rating or recommendation.
EN Nestlé: ten-year FCFF by zone, explicit Russia and Waters deconsolidation, separate Waters/VMS proceeds bridge, three cases, WACC/g and reverse DCF. No rating or recommendation.
EN S&P Global after the Mobility spin: four-segment ten-year FCFF, full EV-to-equity bridge including redeemable NCI, three cases, WACC/g and reverse DCF. No rating or recommendation.
EN SAP: four revenue streams, a full ten-year FCFF, explicit cloud/support migration, SBC, M&A as reinvestment, scenarios, WACC/g and reverse DCF. No rating or recommendation.
TXN · Nasdaq Global Select Market · Estados Unidos
EN Texas Instruments: three segments, a full ten-year FCFF, explicit CHIPS ITC and direct funding, fab capex/D&A, Silicon Labs overlay, scenarios, WACC/g and reverse DCF. No rating or recommendation.
EN Konecranes: three segments, a full ten-year FCFF model, explicit lease convention, guidance versus assumptions, scenarios, WACC/g and reverse DCF. No rating or recommendation.
EN DHL Group: five divisions, a full ten-year FCFF model, explicit lease convention, segment scenarios, WACC/g, reverse DCF, catalysts and falsification tests. No rating or recommendation.
EN LVMH: five business groups, a full ten-year FCFF model, explicit lease convention, scenarios, WACC/g, reverse DCF, China risks and falsification tests. No rating or recommendation.
EN Accenture: five industry groups, ten-year organic and acquisition growth forecast, explicit M&A cash cost, full FCFF, leases, benefits, WACC, scenarios, sensitivities and reverse DCF. No rating or recommendation.
EN PepsiCo: six segments, ten-year volume/price, cost and FCFF forecast, leases, benefits, working capital, scenarios, sensitivities and reverse DCF. Includes euro issuance and KFC risk. No rating or recommendation.
EN Detailed Canadian National Railway model: seven commodity groups, RTM and yield/mix, ten-year FCFF, network costs, capex, NWC, leases, pensions, scenarios and reverse DCF. Conditional values with no rating or recommendation.
EN Detailed Novo Nordisk research: therapy and brand drivers, 340B earnings quality, a ten-year FCFF forecast, pipeline, patent cliff, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
EN Detailed Airbus research: delivery and segment drivers, a ten-year FCFF forecast, customer advances, programme risk, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
EN Detailed Nintendo research: an explicit Switch 2 platform cycle, seven revenue drivers, a ten-year FCFF forecast, balance sheet, associates, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
EN Detailed ASML research: three economic revenue drivers, a full ten-year FCFF forecast, balance-sheet and working-capital treatment, scenarios, sensitivity and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
EN Detailed Microsoft research: eight revenue groups, the two new reporting segments, ten forecast years, AI reinvestment and lease conventions, scenarios and reverse DCF. Values are conditional analyst estimates, with no rating or investment recommendation.
Este arquivo apresenta os relatórios publicados. Os novos relatórios surgem após a análise, as verificações do modelo e a publicação; o relatório mais recente mantém a sua data real de publicação.